Cargando…

Reprogramming human B cells with custom heavy chain antibodies

Mostrar otras versiones (1)

We describe a genome editing strategy to reprogram the immunoglobulin heavy chain (IgH) locus of human B cells to express custom molecules that respond to immunization. These heavy chain antibodies (HCAbs) comprise a custom antigen-recognition domain linked to an Fc domain derived from the IgH locus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Geoffrey L., Huang, Chun, Mathur, Atishay, Huang, Xiaoli, Chen, Hsu-Yu, Stanten, Kalya, Morales, Heidy, Chang, Chan-Hua, Kezirian, Eric J., Cannon, Paula M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371167/ https://www.ncbi.nlm.nih.gov/pubmed/37503066 http://dx.doi.org/10.21203/rs.3.rs-3117686/v1

Ejemplares similares

Reprogramming human B cells with custom heavy chain antibodies
por: Rogers, Geoffrey L., et al.
Publicado: (2023)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Immunoglobulin Heavy Chain Exclusion in the Shark
por: Malecek, Karolina, et al.
Publicado: (2008)

Building a chain of customers
por: Schonberger, Richard J
Publicado: (2007)

Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies
por: Clarke, Starlynn C., et al.
Publicado: (2019)

Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
por: Zou, Xiangang, et al.
Publicado: (2007)

Supply Chains Built for Speed and Customization
por: Sodhi, ManMohan
Publicado: (2017)

Customer Service Supply Chain Management: Models for Achieving Customer Satisfaction, Supply Chain Performance, and Shareholder Value
por: Oliveira, Alexandre
Publicado: (2014)

HEAVY AND LIGHT CHAIN ALLOTYPIC MARKERS ON RABBIT HOMOCYTOTROPIC ANTIBODY
por: Kindt, T. J., et al.
Publicado: (1969)

The Transcriptional Promoter Regulates Hypermutation of the Antibody Heavy Chain Locus
por: Tumas-Brundage, Kathleen, et al.
Publicado: (1997)

High-Resolution Description of Antibody Heavy-Chain Repertoires in Humans
por: Arnaout, Ramy, et al.
Publicado: (2011)

Dynamics of heavy chain junctional length biases in antibody repertoires
por: Sankar, Kannan, et al.
Publicado: (2020)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020)

Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses
por: Xiao, Haixia, et al.
Publicado: (2019)

Reprogramming the antigen specificity of B cells using genome-editing technologies
por: Voss, James E, et al.
Publicado: (2019)

Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma
por: Olagunju, Abdulbaril, et al.
Publicado: (2022)

Characterization of the Recognition Specificity of BH2, a Monoclonal Antibody Prepared against the HLA-B27 Heavy Chain
por: Yu, Hui-Chun, et al.
Publicado: (2015)

Inhibition of kinesin-driven microtubule motility by monoclonal antibodies to kinesin heavy chains
Publicado: (1988)

The association of heavy and light chain variable domains in antibodies: implications for antigen specificity
por: Chailyan, Anna, et al.
Publicado: (2011)

Improving the accuracy of the structure prediction of the third hypervariable loop of the heavy chains of antibodies
por: Messih, Mario Abdel, et al.
Publicado: (2014)

Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains
por: Dong, Jinhui, et al.
Publicado: (2019)

Development of polyclonal heavy chain antibodies targeting programmed death ligand-1
por: Oghalaie, Akbar, et al.
Publicado: (2023)

Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire
por: Rodriguez, Oscar L., et al.
Publicado: (2023)

Expression of heavy chain‐only antibodies can support B‐cell development in light chain knockout chickens
por: Schusser, Benjamin, et al.
Publicado: (2016)

Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells
por: Haryadi, Ryan, et al.
Publicado: (2015)

IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design
por: Stoyle, Chloe L., et al.
Publicado: (2017)

Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
por: Rogers, Geoffrey L., et al.
Publicado: (2021)

DIVERSE EXPRESSION OF GROUP a ALLOTYPE SPECIFICITIES ON THE HEAVY CHAINS OF HOMOGENEOUS RABBIT ANTIBODIES
por: Kindt, Thomas J., et al.
Publicado: (1973)

Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies
por: Li, Xinyang, et al.
Publicado: (2016)

Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
por: Bannas, Peter, et al.
Publicado: (2018)

Optimizing antibody affinity and stability by the automated design of the variable light-heavy chain interfaces
por: Warszawski, Shira, et al.
Publicado: (2019)

A Novel Strategy for Screening Tumor-Specific Variable Domain of Heavy-Chain Antibodies
por: Rafique, Abdur, et al.
Publicado: (2023)

Customer-centric product presentations for monoclonal antibodies
por: Bittner, Beate
Publicado: (2023)

Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
por: Banach, Bailey B., et al.
Publicado: (2021)

Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein
Publicado: (1987)

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation
por: Chen, Hsu-Yu, et al.
Publicado: (2021)

Visualization of cardiac ventricular myosin heavy chain homodimers and heterodimers by monoclonal antibody epitope mapping
Publicado: (1987)

Heterologous Antigen Selection of Camelid Heavy Chain Single Domain Antibodies against Tetrabromobisphenol A
por: Wang, Jia, et al.
Publicado: (2014)

Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors
por: Devarakonda, Charan V., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_45a01nq70mg5to331kp5lcds83